𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group

✍ Scribed by Mitchell H. Gail; Robert T. Eagan; Ronald Feld; Robert Ginsberg; Brian Goodell; Lucius Hill; E. Carmack Holmes; John M. Lukeman; Clifton F. Mountain; Robert K. Oldham; F. G. Pearson; Peter W. Wright; William H. Lake Jr; The Lung Cancer Study Group

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
964 KB
Volume
54
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Overexpression of S100A2 protein as a pr
Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer
✍ Huijun Wang; Zhengdong Zhang; Ruiyun Li; K. Kian Ang; Huazhong Zhang; Nancy P. C πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 313 KB πŸ‘ 2 views

## Abstract S100A2, a calcium‐binding protein, recently became of major interest because of its differential expression during transformation and metastasis in various tumors. The purpose of this study was to investigate the prognostic significance of S100A2 expression in the early‐stage non small

Reduced survival in patients with stage-
Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors
✍ Rafael Rosell; Alex PifarrΓ©; Mariano MonzΓ³; Julio Astudillo; M. Paz LΓ³pez-Cabrer πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 88 KB πŸ‘ 2 views

To better understand whether replication-error-type instability (RER 1 ) is a frequent genetic alteration event in surgicalpathologic stage-I non-small-cell lung cancer (NSCLC) and identify whether it constitutes an independent prognostic parameter, we examined 35 surgical-pathologic stage-I-NSCLC p

Prognostic factors for survival of stage
Prognostic factors for survival of stage I nonsmall cell lung cancer patients : A population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003
✍ S.-H. Ignatius Ou; Jason A. Zell; Argyrios Ziogas; Hoda Anton-Culver πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Platinum‐based adjuvant chemotherapy in randomized trials has failed to provide a survival benefit in patients with resected stage I nonsmall cell lung cancer (NSCLC). Using data from the California Cancer Registry (CCR), we explored factors that had detrimental effects

Intraoperative brachytherapy using gelfo
Intraoperative brachytherapy using gelfoam radioactive plaque implants for resected stage iii non-small cell lung cancer with positive margin: A pilot study
✍ Dr. Dattatreyudu Nori; Xilian Li; Tretorn Pugkhem πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 480 KB

Complete surgical resection of stage I11 non-small cell lung cancer (NSCLC) is at times impossible. Adjuvant radiation therapy is required to sterilize the residual tumor. This study is to investigate the safety, reproducibility, and effectiveness of intraoperative I-125 or Pd-103 Gelfoam plaque imp